Indegene crosses $100 million quarterly revenue as Q3 growth accelerates on pharma demand and AI-led services
● Jan 30, 2026
Indegene Ltd (NSE:INDGN), a life sciences services firm, reported more than 30% year-on-year revenue growth for the December quarter, crossing...
